argenx SE (1AE)
FSX
Closed
Oct 8, 2026
Day's Range
697.4052 wk Range
566.40Overview - 1AE - argenx SE
Key Statistics
Valuation
Enterprise Value
41.92B
P/E (Trailing)
‪36.62‬
Price / Sales (TTM)
‪9.90‬
Price / Book
‪7.20‬
EV / EBITDA
‪29.63‬
Profitability
Gross Margin
‪90.42%‬
Profit Margin
‪32.26%‬
Operating Margin
‪31.99%‬
Return on Assets
‪11.63%‬
Return on Equity
‪23.63%‬
Ownership
Shares Outstanding
62.53M
Float
62.43M
Held by Insiders
‪0.0089%‬
Held by Institutions
‪48.56%‬
Price stats
Beta
‪-0.02‬
50-Day Avg
‪827.44‬
200-Day Avg
‪730.56‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1AE - argenx SE
Peers - 1AE - argenx SE
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines Ltd. American Depositary Shares35.06BMarket Cap+9.68%52-week change63.27P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 1AE - argenx SE
About
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
